Directory
>
Chuck Smith D
Chuck Smith D
Vice President of Patient Safety | Kite Pharma
San Francisco, California, United States
Chuck Smith D
Summary
Chuck Smith D is a seasoned professional with over two decades of experience in the clinical development of biologics and small molecules, currently serving as the Vice President of Patient Safety at Kite, a Gilead Company. His extensive background includes a successful track record in drug safety, clinical trial management, and translational research, particularly in oncology and immunology. Chuck has a unique ability to build and reorganize clinical development teams, ensuring that projects are delivered on time and within budget. He has also contributed significantly to pharmacovigilance and epidemiology efforts across various organizations. His experience spans both large pharmaceutical companies and small biotech firms, giving him a well-rounded perspective on the industry. In addition to his leadership roles, Chuck is known for his strategic thinking and problem-solving skills, which have been instrumental in advancing drug development programs. He is passionate about improving patient safety and outcomes through innovative clinical practices.
Chuck Smith D
Work Experience
Vice President of Patient Safety at
Kite Pharma
October 2021 - Present
Director at
Kite A Gilead
March 2018 - Present
Director, Pharmacovigilance and Epidemiology at
Gilead Sciences
October 2014 - Present
Senior Director of Pharmacovigilance and Epidemiology at
Kite A Gilead
October 2014 - Present
Founder & Chief Medical Officer at
INNOMAB PTE. LTD.
January 2008 - September 2014
Vice-President, Clinical Development at
Cambridge Antibody Technology
December 2005 - October 2007
Senior Director, Clinical Development at
Genencor
February 2002 - November 2005
Senior Clinical Research Physician at
Novartis
June 1996 - January 2002
Clinical Associate at
National Cancer Institute (NCI)
July 1993 - May 1996
Chuck Smith D
Education
State University of New York Downstate Health Sciences University
Frequently Asked Questions about Chuck Smith D
What is Chuck Smith D email address?
Chuck Smith D's primary email address is *****@affitech.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Chuck Smith D work for?
Chuck Smith D is a Vice President of Patient Safety at Kite Pharma, a company specializing in Commercial physical research.
Where Chuck Smith D graduated from?
Chuck Smith D holds a degree in from State University of New York Downstate Health Sciences University .
How can I directly contact Chuck Smith D?
To contact Chuck Smith D directly, you can use the email address *****@affitech.com. Complete contact information is available upon registration with Muraena.
Who is Chuck Smith D?
Chuck Smith D is a seasoned professional with over two decades of experience in the clinical development of biologics and small molecules, currently serving as the Vice President of Patient Safety at Kite, a Gilead Company. His extensive background includes a successful track record in drug safety, clinical trial management, and translational research, particularly in oncology and immunology. Chuck has a unique ability to build and reorganize clinical development teams, ensuring that projects are delivered on time and within budget. He has also contributed significantly to pharmacovigilance and epidemiology efforts across various organizations. His experience spans both large pharmaceutical companies and small biotech firms, giving him a well-rounded perspective on the industry. In addition to his leadership roles, Chuck is known for his strategic thinking and problem-solving skills, which have been instrumental in advancing drug development programs. He is passionate about improving patient safety and outcomes through innovative clinical practices.
Chuck`s contact details
*****@affitech.com
******@kitepharma.com
Colleagues
Executive Director
Executive Director, Technical Partnerships and Portfolio
Vice President Clinical Operations and Data Management
Executive Director Research Operations | Chief of Staff | Cell Therapy | CAR-T
Executive Director of CMC Regulatory Affairs
Executive Director—West, National Cell Therapy
Executive Director, Global Medical Affairs and Clinical Development
Senior Vice President Global Process Development
VP, Global Commercial Strategy, Value & Access
VP & General Manager - International Division